Tyynismaa lab projects
Genetics and stem cell based modeling of axon degeneration diseases
To identify genetic causes of neurological diseases, we utilize genome-wide next-generation sequencing approaches. We investigate the molecular mechanisms of disease mutations by generating patient-specific motor neurons from reprogrammed skin fibroblasts.
- ITPR3 encoding IP3 receptor type 3 (IP3R3) is a disease gene for dominant Charcot-Marie-Tooth disease
- Mitochondrial intermembrane space proteins CHCHD2 or CHCHD10 impact respiration in human motor neurons
- Distinct effects on mRNA export factor GANP cause neuropathy plus phenotypes
- Absence of neurofilament light causes early-onset neuropathy
- ATAD3A in dominant hereditary spastic paraplegia
Mitochondria in cellular proteostasis, and its tissue-specific consequences
We investigate the consequences of disturbed mitochondrial proteostasis on cell and tissue function, as well as the role of mitochondria in maintaining cellular proteostasis. In relation to human disease, we are particularly interest in mitochondrial aminoacyl-tRNA synthetases that are associated with multiple tissue-specific mitochondrial diseases.
- Redox regulation of GRPEL2, the co-chaperone of mitochondrial HSP70
- Editing activity by mitochondrial alanyl-tRNA synthetase is essential in mammals
Neurogenomics in routine diagnostics of children and adults: impact on patient care and cost-effectiveness (pHealth Academy Project)
This project aims to evaluate the effectiveness and impact of current personalised genomic technology as the first-line diagnostic tool in progressive neurological diseases of adults and children. This is a collaboration between University of Helsinki, Helsinki University Hospital, and VATT Institute for Economic Research.